Home›Companies›Biotech & Pharma›Gasami Therapeutics

Gasami Therapeutics, Inc.

Updated Oct 27, 2026·Latest SEC filing Jan 12, 2026·Suggest an edit

About Gasami Therapeutics

Gasami Therapeutics is a private company based in Richmond, Virginia, incorporated in 2025 in Delaware. It has reported $20,000 raised in one offering on Form D since January 2026.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Dec 4, 2025Jan 12, 2026$20,000of $250K target1$20,000DebtRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Gasami Therapeutics's Form D filed Jan 12, 2026.

Sources

  1. SECGasami Therapeutics, Inc. filing history